GSK director Wendy Becker to join Tesco board

GSK plc announced that Wendy Becker, an independent Non-Executive Director of GSK, has been appointed as a Non-Executive Director of Tesco PLC, effective November 1, 2026.

Rhea-AI Filing Summary

GSK plc announced that Wendy Becker, an independent Non-Executive Director of GSK, has been appointed as a Non-Executive Director of Tesco PLC, effective November 1, 2026.

Key Terms

independent Non-Executive Director, UK Listing Rule 6.4.9R(2), Form 20-F

3 terms

independent Non-Executive Director regulatory

"an independent Non-Executive Director"

An independent non-executive director is a board member who is not part of a company’s day-to-day management and has no close ties to major owners, so they can offer unbiased oversight of strategy, risks, and executive pay. For investors, they act like an impartial referee who helps prevent conflicts of interest, improve transparency and hold management accountable, which can reduce governance risk and protect shareholder value.

UK Listing Rule 6.4.9R(2) regulatory

"In accordance with UK Listing Rule 6.4.9R(2)"

Form 20-F regulatory

"annual reports under cover of Form 20-F"

Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What new board role will Wendy Becker take?

Wendy Becker has been appointed as a Non-Executive Director of Tesco PLC, effective November 1, 2026. She is an independent Non-Executive Director of GSK plc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/08/2026 - 11:42 AM Accepted by SEC EDGAR 10/08/2026 - 11:42 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2026

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

Issued: 8 October 2026, London UK

Wendy Becker CBE – New Directorship

In accordance with UK Listing Rule 6.4.9R(2), GSK plc notes that Wendy Becker, an independent Non-Executive Director, has been appointed as a Non-Executive Director of Tesco PLC with effect from 1 November 2026.

V A Whyte

Company Secretary

8 October 2026

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

Registered in England & Wales:

No. 3888792

Registered Office:

79 New Oxford Street

London

WC1A 1DG

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GSK plc

(Registrant)

Date: October 08, 2026

By:/s/ VICTORIA WHYTE

--------------------------

Victoria Whyte

Authorised Signatory for and on

behalf of GSK plc